Institut Català de la Salut
[Lazarus JV] Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. [Miralles-Sanchez JE, Agirre-Garrido L, Brachowicz N, Nicolàs A, Armenta A] Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. [Pericàs JM] Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain. Johns Hopkins University-Pompeu Fabra University Public Policy Center, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-04-29T11:13:20Z
2025-04-29T11:13:20Z
2025-05
City health; Health policy; Liver disease
Salud urbana; Política de salud; Enfermedad hepática
Salut urbana; Política de salut; Malaltia hepàtica
Despite their high prevalence worldwide, steatotic liver diseases (SLDs) are largely excluded from most non-communicable disease (NCD) guidelines and strategies. We propose policies and strategies to achieve the United Nations Sustainable Development Goal of reducing NCD premature mortality by one-third by 2030. To assess this gap—the exclusion of SLDs from NCD policies—in urban areas, we reviewed Barcelona’s strategies for NCD risks (e.g., alcohol, tobacco, healthy food access). We then explored applications of geo-spatial visualisation and whole-of-society approaches (e.g., citizen science engagement) aligned with the World Health Organization (WHO) Best Buys to provide recommendations to address NCDs, generally, and SLDs specifically.
JVL, JEMS, LAG, NB, AN, AA, DB, LRD, and DIW acknowledge support to ISGlobal from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program.
Artículo
Versión publicada
Inglés
Salut urbana; Política sanitària; Fetge - Malalties - Tractament; DISEASES::Digestive System Diseases::Liver Diseases; Other subheadings::Other subheadings::/therapy; HEALTH CARE::Health Care Economics and Organizations::Policy::Social Control Policies::Public Policy::Health Policy; PUBLIC HEALTH::Health Care (Public Health)::Health of Specific Groups::Urban Health; ENFERMEDADES::enfermedades del sistema digestivo::enfermedades hepáticas; Otros calificadores::Otros calificadores::/terapia; ATENCIÓN DE SALUD::economía y organizaciones para la atención de la salud::políticas::políticas de control social::política pública::política sanitaria; SALUD PÚBLICA::atención a la salud (salud pública)::salud de grupos específicos::salud urbana
Elsevier
The Lancet Regional Health - Europe;52
https://doi.org/10.1016/j.lanepe.2025.101272
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles científics - VHIR [1655]